AASLD Celebrates World MASH Day
As the global burden of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated...
As the global burden of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated...
New program empowers the medical community at the point of care to improve patient outcomes and change the trajectory of liver...
This comprehensive educational program provides a practical update on key issues in modern hepatology across the disease spectrum. Learners explore reproductive health considerations in patients with chronic liver disease, including counseling, pregnancy planning, and management considerations. The course also delivers timely updates on hepatocellular carcinoma and hepatitis B, with a focus on evolving screening, treatment, and long-term management strategies.
Subsequent presentations address spontaneous bacterial peritonitis prophylaxis and emerging insights into progressive familial intrahepatic cholestasis and cholestatic pruritus management. The program concludes with focused discussions on frailty in liver disease and the expanding role of glucagon-like peptide-1 receptor agonist (GLP-1 RA)–based therapies. Designed for clinicians, this course emphasizes evidence-based care and practical application to improve patient outcomes.
This timely course provides a comprehensive overview of obesity as a multisystem disease with major implications for liver health. Using the frameworks of metabolic dysfunction–associated steatotic liver disease (MASLD) and cardiometabolic-kidney-liver-metabolic disease (CKLM), the course integrates pathophysiology, noninvasive risk stratification, and therapeutic approaches across lifestyle, pharmacologic, and procedural interventions. Panelists emphasize clinically relevant concepts for hepatologists navigating the rapidly evolving obesity and metabolic disease landscape.
This workshop introduces the concept of point-of-care ultrasonography (POCUS) of the liver as an extension of the clinical exam to be performed by hepatology clinicians. Presenters provide a rationale for the use of POCUS, the basics of liver ultrasonography, common applications, and a path to implement POCUS in clinical practice. Participants receive hands-on training for performing POCUS examinations of the liver.
This workshop provides advanced training for use of liver point-of-care ultrasonography (POCUS). It is intended for professionals who have previously completed the Basic Skills Liver POCUS course at The Liver Meeting or Digestive Disease Week. The workshop includes a theoretical portion focusing on assessment of inpatient liver findings using POCUS, liver elastography, and advice on implementing liver POCUS in clinical practice. A hands-on session follows with an approach to specific liver findings instead of normal liver anatomy. The workshop concludes with a question-and-answer period.
IMPORTANT NOTE: To register for this session, participants must either be registered for the Basic Skills Liver POCUS Workshop at The Liver Meeting 2026 or have previously completed a Basic Skills Liver POCUS Workshop at The Liver Meeting 2025 or Digestive Disease Week 2026.
Developed by the Patient Advisory Group, this informative session explores the evolution of transplantation (ideal versus less-than-ideal donors) and the impact of machine perfusion on liver transplants. Presenters discuss challenges for long-term transplant survivors including models to inform. The patient perspective is shared with a discussion of mental health challenges, including hepatic encephalopathy, depression, and family discussions. Panelists also touch on transplant access disparities and how patients can overcome them.
Pediatric and rare liver diseases present unique diagnostic, therapeutic, and psychosocial challenges for children and their families. Delayed diagnosis, limited treatment options, fragmented care, and inequitable access to specialty services continue to impact outcomes across the lifespan. Program presenters provide an overview of challenges and solutions, and share a view of what may be in store in the future.
Developed by Patient Advisory Group, this session examines the importance of the patient experience within research and clinical care with a focus on cholestatic liver disease—especially primary sclerosing cholangitis (PSC). Session themes include issues of delayed diagnosis, fragmented care, unmet symptom burdens, and ways to improve the patient experience through better care coordination.
This unique program brings together patients, caregivers, and clinicians to share stories and practical advice about living with liver disease. Caregivers discuss supporting a loved one with liver disease—the emotional ups and downs, stress, and self-care. Panelists address mental health concerns, reducing stigma, effective communication with health care practitioners, and transitioning from pediatric to adult health care. Speakers also highlight dealing with hepatologist desserts and working in rural health care with telehealth. Patients, caregivers, family members, and health care practitioners all stand to gain useful tools and confidence to navigate liver disease together.